Ligand binding and aggregation of pathogenic SOD1
暂无分享,去创建一个
Svetlana V. Antonyuk | Richard W. Strange | S. Antonyuk | R. Strange | Gareth S. A. Wright | Gareth S.A. Wright | Neil M. Kershaw | S Samar Hasnain | S. Samar Hasnain | N. Kershaw | G. Wright
[1] S. Hasnain,et al. The structural plasticity of the human copper chaperone for SOD1: insights from combined size-exclusion chromatographic and solution X-ray scattering studies. , 2011, The Biochemical journal.
[2] D. Borchelt,et al. Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease , 2009, Human molecular genetics.
[3] M. Pericak-Vance,et al. Prognosis in Familial Amyotrophic Lateral Sclerosis , 1997, Neurology.
[4] E. Rogaeva,et al. A mechanism for low penetrance in an ALS family with a novel SOD1 deletion , 2009, Neurology.
[5] P. Leigh,et al. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[6] Dmitri I. Svergun,et al. Uniqueness of ab initio shape determination in small-angle scattering , 2003 .
[7] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[8] A. Trapananti,et al. Interaction of cisplatin with human superoxide dismutase. , 2012, Journal of the American Chemical Society.
[9] M. Oliveberg. Waltz, an exciting new move in amyloid prediction , 2010, Nature Methods.
[10] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[11] Robert H. Brown,et al. Familial Amyotrophic Lateral Sclerosis-associated Mutations Decrease the Thermal Stability of Distinctly Metallated Species of Human Copper/Zinc Superoxide Dismutase* , 2002, The Journal of Biological Chemistry.
[12] G. David,et al. Combined sampler robot and high-performance liquid chromatography: a fully automated system for biological small-angle X-ray scattering experiments at the Synchrotron SOLEIL SWING beamline , 2009 .
[13] J. Agar,et al. Tryptophan 32 Potentiates Aggregation and Cytotoxicity of a Copper/Zinc Superoxide Dismutase Mutant Associated with Familial Amyotrophic Lateral Sclerosis* , 2007, Journal of Biological Chemistry.
[14] N. M. Karabacak,et al. A Common Property of Amyotrophic Lateral Sclerosis-associated Variants , 2009, The Journal of Biological Chemistry.
[15] Wolfgang Kabsch,et al. Integration, scaling, space-group assignment and post-refinement , 2010, Acta crystallographica. Section D, Biological crystallography.
[16] H. Horvitz,et al. Identification of three novel mutations in the gene for Cu Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis , 1995, Neuromuscular Disorders.
[17] Bryan F. Shaw,et al. Metal-free Superoxide Dismutase-1 and Three Different Amyotrophic Lateral Sclerosis Variants Share a Similar Partially Unfolded β-Barrel at Physiological Temperature* , 2009, The Journal of Biological Chemistry.
[18] N. Agar,et al. Protein Aggregation and Protein Instability Govern Familial Amyotrophic Lateral Sclerosis Patient Survival , 2008, PLoS biology.
[19] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[20] David S Wishart,et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells , 2011, Proceedings of the National Academy of Sciences.
[21] I. Fridovich,et al. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.
[22] J Günter Grossmann,et al. The application of hybrid pixel detectors for in-house SAXS instrumentation with a view to combined chromatographic operation. , 2013, Journal of synchrotron radiation.
[23] O. Hardiman,et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. , 2000, Archives of neurology.
[24] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[25] Dmitri I. Svergun,et al. Determination of the regularization parameter in indirect-transform methods using perceptual criteria , 1992 .
[26] Ammar Al-Chalabi,et al. ALSOD: The Amyotrophic Lateral Sclerosis Online Database , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[27] Peter T Lansbury,et al. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] Owen Johnson,et al. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.
[29] N. Laing,et al. Toxic mutants in Charcot's sclerosis , 1995, Nature.
[30] I. Polikarpov,et al. Determination of the molecular weight of proteins in solution from a single small-angle X-ray scattering measurement on a relative scale , 2010 .
[31] K. Bushby,et al. CNS tissue Cu/Zn superoxide dismutase (SOD1) mutations in motor neurone disease (MND) , 1997, NeuroReport.
[32] Peter T Lansbury,et al. Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods. , 2010, Journal of medicinal chemistry.
[33] I. Bertini,et al. The Unusually Stable Quaternary Structure of Human Cu,Zn-Superoxide Dismutase 1 Is Controlled by Both Metal Occupancy and Disulfide Status* , 2004, Journal of Biological Chemistry.
[34] I. Bertini,et al. SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization , 2008, PloS one.
[35] I. Bertini,et al. Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS , 2007, Proceedings of the National Academy of Sciences.
[36] Jared R. Auclair,et al. Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis , 2010, Proceedings of the National Academy of Sciences.
[37] S. Antonyuk,et al. Structural discovery of small molecule binding sites in Cu-Zn human superoxide dismutase familial amyotrophic lateral sclerosis mutants provides insights for lead optimization. , 2010, Journal of medicinal chemistry.
[38] Kenji Nakashima,et al. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[39] Robert H. Brown,et al. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. , 2004, Biochemistry.
[40] S. Antonyuk,et al. X-ray crystallography and computational docking for the detection and development of protein-ligand interactions. , 2013, Current medicinal chemistry.
[41] A. Bertolotti,et al. Exposure of Hydrophobic Surfaces Initiates Aggregation of Diverse ALS-Causing Superoxide Dismutase-1 Mutants , 2010, Journal of molecular biology.
[42] J Günter Grossmann,et al. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[43] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[44] P. Lansbury,et al. A possible therapeutic target for Lou Gehrig's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Borchelt,et al. High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation , 2002, Neurobiology of Disease.
[46] B. Geng,et al. Endogenous sulfur dioxide protects against isoproterenol-induced myocardial injury and increases myocardial antioxidant capacity in rats , 2011, Laboratory Investigation.
[47] A. Chakrabartty,et al. Monomeric Cu,Zn-superoxide Dismutase Is a Common Misfolding Intermediate in the Oxidation Models of Sporadic and Familial Amyotrophic Lateral Sclerosis*[boxs] , 2004, Journal of Biological Chemistry.
[48] S. Dunn,et al. Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS , 2011, Proceedings of the National Academy of Sciences.
[49] B. Kennedy,et al. Structural changes to monomeric CuZn superoxide dismutase caused by the familial amyotrophic lateral sclerosis-associated mutation A4V. , 2009, Biophysical journal.
[50] Dmitri I. Svergun,et al. PRIMUS: a Windows PC-based system for small-angle scattering data analysis , 2003 .
[51] Nikolay V Dokholyan,et al. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Joseph,et al. The carbonate radical anion-induced covalent aggregation of human copper, zinc superoxide dismutase, and alpha-synuclein: intermediacy of tryptophan- and tyrosine-derived oxidation products. , 2004, Free radical biology & medicine.
[53] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[54] N. Nukina,et al. Mutation-dependent Polymorphism of Cu,Zn-Superoxide Dismutase Aggregates in the Familial Form of Amyotrophic Lateral Sclerosis* , 2010, The Journal of Biological Chemistry.
[55] Can Kayatekin,et al. Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase. , 2008, Journal of molecular biology.
[56] N. C. Price,et al. The application of circular dichroism to studies of protein folding and unfolding. , 1997, Biochimica et biophysica acta.
[57] D I Svergun,et al. Determination of domain structure of proteins from X-ray solution scattering. , 2001, Biophysical journal.